Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
-
VitalHub Reports Third Quarter 2024 Results
-
CPI Aerostructures Reports Third Quarter and Nine Month 2024 Results
-
KWESST Receives NASDAQ Minimum Bid Price Requirement Extension
-
Spectrum Brands Holdings Announces a 12% Increase in Dividend Payout, Declares Quarterly Common Stock Dividend of $0.47 Per Share
-
CORRECTING and REPLACING Professors from Georgia Tech and University of Michigan to be Honored for Excellence in Semiconductor Research
-
Aion Therapeutic Announces Revocation of MCTO
-
Liberty Gold Reports Q3 2024 Financial and Operating Results
-
Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States
-
Mahershala Ali to Receive the Muhammad Ali Voice of Humanity Honor from the Society of Voice Arts and Sciences, Underwritten by Audible
-
SmartCentres Real Estate Investment Trust Releases Third Quarter Results for 2024
-
Biglari Capital Corp. Issues Letter to Shareholders of Cracker Barrel Old Country Store, Inc.
-
New York Times Bestselling Authors Commemorate Children’s Classic Brown Bear, Brown Bear, What Do You See? with New Picture Book Teaching the Colors of the Rainbow
-
Make a Festive Statement with Gemmy's Large Christmas Airblown® Inflatables
-
KBRA Comments on Aviation ABS Exposure to Spirit Airlines
-
Tide Craft Boats Announces Partnership with Rockford Fosgate as New OEM Partner
-
SmartStop Self Storage REIT, Inc. Reports Third Quarter 2024 Results
-
CAPITAL INSURANCE GROUP RECEIVES A (EXCELLENT) RATING FROM AM BEST
-
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
-
Copa Holdings Announces Monthly Traffic Statistics for October 2024
-
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
-
Northland Power Reports Third Quarter 2024 Results
-
Northland Power Reports Third Quarter 2024 Results
-
Goldmoney Inc. Responds to Property Purchase Media Reports
-
KBRA Assigns Rating to FS KKR Capital Corp.'s $600 Million Senior Unsecured Notes
-
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
-
Dell Technologies to Hold Conference Call Nov. 26 to Discuss Third Quarter Fiscal 2025 Financial Results
-
Stanley Black & Decker To Host 2024 Capital Markets Day On November 20th
-
XLCS Partners advises Mitchell Aircraft on sale of Mitchell PMA to Jet Parts Engineering
-
Dundee Corporation Executes on Key Strategic Initiatives and Announces Q3 Profit
-
EPIC Insurance Brokers & Consultants Announces Expanded Leadership
-
Silver X Mining Announces Termination of Private Placement
-
Johnson//Becker Files Lawsuit Against NuWave, LLC. Over Injuries Suffered by Pressure Cooker
-
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
-
Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program
-
Workhorse Reschedules Third Quarter 2024 Earnings Call to Tuesday, November 19, 2024 at 10:00 a.m. ET
-
B2Gold Announces Drilling Results from its 2024 Exploration Program at the Goose Project; Drill Results at the Nuvuyak Deposit and Mammoth Target Demonstrate Potential to Further Extend the Mine Life
-
ALLOS: FFO GROWS 37%
-
Geo Week Announces 2025 Conference Program and Speakers
-
Final Cut Pro 11 begins a new chapter for video editing on Mac
-
Creating a Legacy: Kingbird Invites You to a Lifestyle of Privacy and Freedom Near Wilmington
-
Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results
-
Strathcona Resources Ltd. Reports Third Quarter 2024 Financial and Operating Results, Provides 2025 Guidance and Announces Quarterly Dividend
-
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II
-
RE Royalties Announces Second Tranche Closing of Private Placement of Series 4 Secured Green Bonds
-
Yangaroo Announces Resignation of Chief Financial Officer
-
Afya Limited Third Quarter and Nine Months 2024 Financial Results
-
Tantalus Systems Holding Inc. Reports Financial Results for Three and Nine Months Ended September 30, 2024
-
DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement
-
Westgate River Ranch Resort & Rodeo Begins Construction on River Country Water Park in Central Florida

